Drugs / Guilisine
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02855307 Comparator | Sep 2016 → Dec 2018 | type 1 diabetes mellitus | Montreal Clinical Research Institute | Completed | No outcome recorded |
| Phase 2 | NCT02416765 Comparator | May → Oct 2015 | type 1 diabetes mellitus | Montreal Clinical Research Institute | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Guilisine | “Patient's usual fast acting insulin analog (Lispro, Aspart or Guilisine) will be infused using the patient's pump.” NCT02855307 ↗ |